1-101804544-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_058170.4(OLFM3):c.1071T>A(p.Asp357Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,612,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_058170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OLFM3 | NM_058170.4 | c.1071T>A | p.Asp357Glu | missense_variant | 6/6 | ENST00000370103.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OLFM3 | ENST00000370103.9 | c.1071T>A | p.Asp357Glu | missense_variant | 6/6 | 1 | NM_058170.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151746Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250594Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135416
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460800Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 726720
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151746Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74088
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.1071T>A (p.D357E) alteration is located in exon 6 (coding exon 6) of the OLFM3 gene. This alteration results from a T to A substitution at nucleotide position 1071, causing the aspartic acid (D) at amino acid position 357 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at